Avacta Group plc – Completion of £5.13m placing with existing investors

10 Jan 2012

Completion of £5.13m Placing with Existing Investors
 Completion of Acquisition of Aptuscan Limited

Further to the announcement made on 9 January 2012, Avacta Group plc (AIM:AVCT), a leading healthcare technology, reagents and consumables company providing proprietary analytical and diagnostics solutions to the life sciences/healthcare sector, is pleased to announce the completion of the Placing and the Acquisition of Aptuscan Limited, following admission of the Placing Shares, the Consideration Shares, the JSOP Shares and the Theragenetics Shares to trading on AIM ("Admission") at 8.00am this morning.

Following Admission, the number of ordinary shares in issue in the Company is 3,156,844,912.

Please see RNS for full announcement.

^ Top of page